AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) said members of its management team will participate in several investor conferences in June 2026, including the Jefferies Global Healthcare Conference in New York, the Oppenheimer CNS and Neuro-Muscular Summit in Miami, the HCW Neuro Perspectives Hybrid Conference and UBS Virtual CNS Day.
The clinical-stage biotech company said executives will take part in fireside chats, presentations and one-on-one meetings, with live and archived webcasts available on its investor relations website.